BOLT (Bolt Biotherapeutics) 6-Month Price Index: 0.87 (As of Sep. 06, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOLT Bolt Biotherapeutics Inc BOLT
59 GF Score
Price $3.90
GF Value $6.26
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Bolt Biotherapeutics 6-Month Price Index?

Bolt Biotherapeutics BOLT +0.13% 59 6-Month Price Index is 0.87 as of Sep. 06, 2026. GuruFocus rates BOLT with a GF Score™ of 59/100 and a GF Value™ of $6.26 (Possible Value Trap). The stock has 5 warning signs investors should review.

6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. It’s calculated by current share price divided by share price 6-months ago. As of today (2026-09-06), Bolt Biotherapeutics's 6-Month Price Index is 0.87.

Bolt Biotherapeutics  (NAS:BOLT) 6-Month Price Index Explanation

Price Index (PI) also called momentum. Strategies involving Price Index are also known as momentum strategies as they allow investors to profit from a company’s stock price. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago.

The investment strategy for momentum investors is to buy winners and sell losers. That is, buy stocks that performed well and sell stocks that performed poorly in the past.

Bolt Biotherapeutics 6-Month Price Index Related Terms

BOLT vs NCNA, CELZ, CURX: 6-Month Price Index Comparison

For the Biotechnology subindustry, Bolt Biotherapeutics's 6-Month Price Index, along with its competitors' market caps and 6-Month Price Index data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BOLT
59GF Score
Bolt Biotherapeutics Inc BOLT
6-Month Price Index is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bolt Biotherapeutics  (NAS:BOLT) 6-Month Price Index Calculation

6-Month Price Index is calculated as following:

6-Month Price Index=Current Share Price / Share Price 6-Months Ago

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 6-Month Price Index →
What does a 6-Month Price Index of 0.87 mean?
Bolt Biotherapeutics (BOLT) has a 6-Month Price Index of 0.87 as of Sep. 06, 2026. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on Bolt Biotherapeutics and its competitors.
Is Bolt Biotherapeutics' 6-Month Price Index too high?
Bolt Biotherapeutics' current 6-Month Price Index is 0.87. Overall, Bolt Biotherapeutics has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bolt Biotherapeutics' 6-Month Price Index compare to NCNA and CELZ?
Bolt Biotherapeutics' 6-Month Price Index of 0.87 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 6-Month Price Index for a Biotechnology company?
A good 6-Month Price Index depends on the Biotechnology industry context. However, 6-Month Price Index should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 6-Month Price Index mean?
A high 6-Month Price Index can signal that a stock is expensive relative to its fundamentals. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on Bolt Biotherapeutics and its competitors. Bolt Biotherapeutics's current 6-Month Price Index is 0.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bolt Biotherapeutics stock overvalued right now?
Based on GuruFocus' analysis, Bolt Biotherapeutics (BOLT) is currently considered Possible Value Trap. The stock's GF Value™ is $6.26, compared to a current price of $3.90 — trading 37.7% below its estimated fair value. The current 6-Month Price Index is 0.87. Bolt Biotherapeutics' overall GF Score™ is 59/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 6-Month Price Index calculated?
6-Month Price Index is calculated from a company's financial statements. For Bolt Biotherapeutics (BOLT), the current 6-Month Price Index is 0.87 as of Sep. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bolt Biotherapeutics (BOLT) Overvalued in 2026?

Based on GuruFocus' analysis, Bolt Biotherapeutics stock appears to be undervalued. The current stock price of $3.90 is trading 37.7% below its estimated GF Value™ of $6.26. GuruFocus considers Bolt Biotherapeutics to be Possible Value Trap.

Key valuation signals for BOLT:

  • 6-Month Price Index: 0.87
  • GF Value™: $6.26 vs. price of $3.90 (37.7% below fair value)
  • GF Score™: 59/100 with 5 warning signs

No single metric tells the full story. See the BOLT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bolt Biotherapeutics Business Description

Address 900 Chesapeake Drive, Redwood City, CA, USA, 94063
Bolt Biotherapeutics Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The company is focused on the clinical development of BDC-4182, its claudin 18.2 ISAC. Its other pipeline programs include CEA ISAC program a Boltbody ISAC targeting carcinoembryonic antigen cell adhesion molecule 5, or CEA; PD-L1 ISAC utilizes a novel human anti-PD-L1 antibody conjugated to a next-generation TLR7/8 agonist payload via a non-cleavable linker; and BDC-3042, its dectin-2 agonist antibody program, developed to repolarize critical cells in the tumor microenvironment known as tumor associated macrophages. It operates in single segment.
59GF Score

Get the complete analysis for BOLT

6-Month Price Index is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.90
Price
$6.26
GF Value